Cigna Group $CI Shares Bought by CenterBook Partners LP

CenterBook Partners LP increased its position in Cigna Group (NYSE:CIFree Report) by 148.5% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 4,531 shares of the health services provider’s stock after buying an additional 2,708 shares during the quarter. CenterBook Partners LP’s holdings in Cigna Group were worth $1,306,000 at the end of the most recent reporting period.

Other hedge funds have also recently bought and sold shares of the company. Harbor Capital Advisors Inc. boosted its position in shares of Cigna Group by 119.5% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 90 shares of the health services provider’s stock valued at $26,000 after purchasing an additional 49 shares in the last quarter. Solstein Capital LLC bought a new stake in shares of Cigna Group in the 2nd quarter worth approximately $29,000. Chilton Capital Management LLC acquired a new stake in Cigna Group during the second quarter valued at approximately $30,000. Collier Financial bought a new stake in Cigna Group during the third quarter worth approximately $34,000. Finally, Quaker Wealth Management LLC grew its position in Cigna Group by 201.0% in the second quarter. Quaker Wealth Management LLC now owns 106 shares of the health services provider’s stock worth $35,000 after buying an additional 211 shares during the last quarter. 86.99% of the stock is owned by institutional investors and hedge funds.

Cigna Group Stock Performance

Shares of CI stock opened at $280.41 on Friday. The stock’s fifty day simple moving average is $278.91 and its 200-day simple moving average is $284.09. The company has a market capitalization of $74.90 billion, a price-to-earnings ratio of 12.64, a P/E/G ratio of 0.99 and a beta of 0.27. The company has a current ratio of 0.74, a quick ratio of 0.76 and a debt-to-equity ratio of 0.74. Cigna Group has a 1-year low of $239.51 and a 1-year high of $350.00.

Cigna Group (NYSE:CIGet Free Report) last announced its quarterly earnings data on Thursday, February 5th. The health services provider reported $8.08 EPS for the quarter, topping analysts’ consensus estimates of $7.88 by $0.20. The firm had revenue of $72.50 billion during the quarter, compared to analyst estimates of $69.53 billion. Cigna Group had a return on equity of 19.46% and a net margin of 2.17%.The business’s quarterly revenue was up 10.4% compared to the same quarter last year. During the same period last year, the company posted $6.64 EPS. Cigna Group has set its FY 2026 guidance at 30.250- EPS. On average, sell-side analysts predict that Cigna Group will post 29.77 earnings per share for the current fiscal year.

Cigna Group Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, March 19th. Investors of record on Thursday, March 5th will be given a dividend of $1.56 per share. The ex-dividend date of this dividend is Thursday, March 5th. This is a positive change from Cigna Group’s previous quarterly dividend of $1.51. This represents a $6.24 dividend on an annualized basis and a yield of 2.2%. Cigna Group’s payout ratio is 27.23%.

Analyst Ratings Changes

A number of brokerages have recently commented on CI. Weiss Ratings reiterated a “hold (c-)” rating on shares of Cigna Group in a research report on Monday, December 29th. TD Cowen boosted their target price on Cigna Group from $333.00 to $338.00 and gave the stock a “buy” rating in a research report on Monday, February 9th. Zacks Research upgraded Cigna Group from a “strong sell” rating to a “hold” rating in a research report on Monday, January 5th. Morgan Stanley reissued an “overweight” rating and issued a $355.00 price target on shares of Cigna Group in a research note on Friday, October 31st. Finally, Raymond James Financial reaffirmed a “strong-buy” rating on shares of Cigna Group in a research note on Monday, November 3rd. One analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and five have given a Hold rating to the company. Based on data from MarketBeat, Cigna Group currently has a consensus rating of “Moderate Buy” and an average price target of $330.63.

Get Our Latest Report on CI

Cigna Group Company Profile

(Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

See Also

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.